BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2787853)

  • 1. Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's disease.
    Facchetti F; De Wolf-Peeters C; van den Oord JJ; Desmet VJ
    J Pathol; 1989 May; 158(1):57-65. PubMed ID: 2787853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
    Poppema S
    Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
    Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
    Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
    Ohsawa M; Aozasa K; Ikeda H
    Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
    Pinkus GS; Said JW
    Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.
    Foss HD; Herbst H; Gottstein S; Demel G; Araujó I; Stein H
    Am J Pathol; 1996 Apr; 148(4):1229-36. PubMed ID: 8644863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of monocytoid B-lymphocytes in Hodgkin's disease.
    Ohsawa M; Kanno H; Naka N; Aozasa K
    Mod Pathol; 1994 Jun; 7(5):540-3. PubMed ID: 7937719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic attributes of the malignant cell population in Hodgkin's disease indicate a monocyte/macrophage origin.
    Olsson L; Behnke O
    Cancer Surv; 1985; 4(2):421-38. PubMed ID: 3842320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-predominance Hodgkin's disease.
    Poppema S
    Semin Diagn Pathol; 1992 Nov; 9(4):257-64. PubMed ID: 1480848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.